It is the pleasure of Friends Research Institute to announce that Dr. Mishka Terplan, Associate Medical Director since 2019, assumed the role of Medical Director on August 1, 2021. Dr. Terplan is board certified in Addiction Medicine and Obstetrics and Gynecology. He is a Fellow of the American Congress of Obstetricians and Gynecologists, a Distinguished Fellow of the American Society of Addiction Medicine, and a member of the College on Problems of Drug Dependence. His research has focused on reproductive health for people who use drugs, development of guidance for care of pregnant women with substance use disorders, and the public health response to the opioid crisis. More recently, Dr. Terplan has been instrumental in the interpretation of federal, state, and local guidance related to the SARS-CoV-2 virus and the development of workplace policies related to the SARS-CoV-2 virus to ensure the safety of FRI’s employees and study participants. In addition to his medical oversight duties, Dr. Terplan also plans to continue his research in reproductive health and the treatment of substance use disorders.
A sample of Dr. Terplan’s publications can be found on his bio page at: https://friendsresearch.org/people/mishka-terplan-m-d-m-p-h-facog-dfasam/?val=r.